Anti-inflammatory Effects of a Crude Hydroethanolic Sideritis cilicica Extract on LPS-Induced Gene Expression in RAW 264.7 Macrophages

In the human body, a specific type of immune cell called a macrophage acts as a first responder to danger. When these cells detect a threat, such as a piece of bacteria, they release chemical signals to rally the rest of the immune system and begin the repair process. This reaction, known as inflammation, is a vital defense mechanism. However, when this response becomes too strong or lasts too long, it can damage healthy tissue and contribute to chronic diseases. Scientists often study this process by introducing a component of bacterial walls, called lipopolysaccharide, into a culture of these cells. This triggers a predictable surge of inflammatory signals, allowing researchers to test whether natural substances can calm the reaction without harming the cells themselves.

For centuries, people in Turkey and the Mediterranean have brewed teas from plants in the Sideritis genus, believing they offer health benefits, including relief from inflammation. While these plants are known to contain compounds that fight oxidation and microbes, the specific way they interact with the genetic instructions inside immune cells has remained largely unexplored. A researcher at Kilis 7 Aralik University and the Karolinska Institutet set out to investigate this gap using a specific plant native to Turkey called Sideritis cilicica. The goal was not to create a new medicine immediately, but to see if a simple extract from this plant could stop the genetic switches that turn on inflammation when immune cells are under attack.

The team began by gathering dried leaves, stems, and flowers of Sideritis cilicica from a local herbal shop. They ground the plant material into a fine powder and soaked it in a mixture of water and ethanol for two days to draw out the active compounds. After filtering the liquid and removing the solvent, they were left with a dark brown, crude extract. Before testing its effects on inflammation, the researchers had to ensure the substance was safe for the cells. They exposed mouse immune cells to various concentrations of the extract, ranging from very low to very high doses. They found that at lower levels, the cells remained healthy and active, but at higher doses, the extract began to kill them. This established a safe window for testing, where the extract could be applied without destroying the very cells it was meant to protect.

With the safe concentrations identified, the researchers moved to the main experiment. They took a fresh batch of immune cells and divided them into groups. One group received a standard culture medium, while another was exposed to the bacterial trigger to induce a strong inflammatory response. Two additional groups were pre-treated with the plant extract before receiving the bacterial trigger. The researchers then measured the levels of specific genes that act as the blueprints for inflammatory proteins. These included genes that produce signaling molecules like interleukin-6 and tumor necrosis factor, as well as genes that create enzymes responsible for further inflammation.

The results showed a clear pattern. When the cells were exposed to the bacterial trigger alone, the levels of these inflammatory genes skyrocketed, confirming that the immune system was in full alarm mode. However, in the groups that had been pre-treated with the plant extract, the rise in these genes was significantly dampened. The effect was dose-dependent, meaning that the higher concentration of the extract, specifically one hundred micrograms per milliliter, produced a stronger reduction in gene activity than the lower concentration. The extract did not turn off the genes completely, but it substantially lowered the volume of the inflammatory signal. Crucially, the extract alone, without the bacterial trigger, did not cause any change in the cells, indicating that it does not suppress normal cell function or cause harm on its own.

The study focused on the genetic level, measuring the RNA copies that cells make before they produce the actual proteins. The researchers observed that the extract reduced the production of these RNA copies for the key inflammatory markers. This suggests that the plant extract interferes with the early stages of the immune response, preventing the cell from even starting the process of making large amounts of inflammatory signals. While the study did not identify the specific chemical compounds within the extract responsible for this effect, the presence of known bioactive substances in Sideritis plants, such as flavonoids and phenolic acids, offers a plausible explanation. The findings provide a molecular basis for the traditional use of these plants, showing that they can indeed quiet the immune system's alarm bells.

Despite these promising results, the researchers are careful to note the limits of their work. The experiment was conducted in a dish using mouse cells, not in a living human, and the method used to measure gene activity provides a semi-quantitative view rather than a precise count. The study did not measure the actual proteins released by the cells or the specific chemicals inside the plant extract. Therefore, while the data strongly suggests that Sideritis cilicica has anti-inflammatory properties, it does not yet prove how it works or if it would be effective as a treatment in people. The work serves as a solid starting point, confirming that this endemic Turkish plant contains compounds capable of modulating inflammation, and paving the way for more detailed investigations into its chemical makeup and mechanisms.